World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
42
Citations
7508
World Ranking
4886
National Ranking
2186

Overview

Allan D. Hess is affiliated with Johns Hopkins University in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with significant contributions also in Medicine.

They have published work across several closely related subfields, including Molecular Biology, Immunology, Oncology, Biotechnology, and Immunology and Allergy. Their focus encompasses several main topics such as Pancreatic and Hepatic Oncology Research, Immunotherapy and Immune Responses, RNA Interference and Gene Delivery, Glycosylation and Glycoproteins Research, Immune cells in cancer, Cancer Research and Treatments, and Ubiquitin and proteasome pathways.

The scientist's recent publications include:

  • C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences, 2025, Pharmaceutics
  • Abstract 2570: Deciphering local immunosuppression in pancreatic cancer: targeting CAF-myeloid cell crosstalk to enhance immune response, 2025, Cancer Research
  • Abstract B098: RAS(ON) multi-selective inhibition remodels cancer-associated fibroblast subtypes and extracellular matrix in pancreatic cancer, 2025, Cancer Research
  • Abstract B097: pan-RAS-GTP inhibition relieves angiosuppression in PDAC by repressing Hedgehog paracrine signaling, 2025, Cancer Research

Allan D. Hess frequently collaborates with the following researchers:

  • Marie C. Hasselluhn
  • Tanner C. Dalton
  • Stephen A. Sastra
  • Carmine F. Palermo
  • Andrea Califano

Their work is consistently published in journals such as Cancer Research and Pharmaceutics, with three publications in the former and one in the latter. Their research contributions are primarily concentrated on molecular mechanisms underlying cancer development and immunological responses within oncological contexts.

Best Publications

  • Thalidomide for the treatment of chronic graft-versus-host disease.

    G B Vogelsang;E R Farmer;A D Hess;V Altamonte

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • Association of Foxp3 regulatory gene expression with graft-versus-host disease

    Yuji Miura;Christopher J. Thoburn;Emilie C. Bright;Michele L. Phelps

  • Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

    Christopher G. Kanakry;Sudipto Ganguly;Marianna Zahurak;Javier Bolaños-Meade

  • Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.

    Paul M. Colombani;Adelaide Robb;Allan D. Hess

  • Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.

    Allan D. Hess;Louis Horwitz;William E. Beschorner;George W. Santos

  • INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

    Richard J. Jones;Allan D. Hess;Risa B. Mann;Steven Piantadosi

  • Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

    Unknown

  • Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.

    A D Hess;P J Tutschka;G W Santos

  • Human immunodeficiency virus induces phosphorylation of its cell surface receptor.

    Alan P. Fields;Daniel P. Bednarik;Allan Hess;W. Stratford May

  • Successful Treatment of Murine Melanoma with Bryostatin 1

    Lynn M. Schuchter;Ahmed H. Esa;W. Stratford May;Mary K. Laulis

  • Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide

    Allan D. Hess;Emilie C. Bright;Christopher Thoburn;Georgia B. Vogelsang

  • Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.

    A D Hess;P J Tutschka;Z Pu;G W Santos

  • An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.

    Georgia B. Vogelsang;Allan D. Hess;Aron W. Berkman;Peter J. Tutschka

  • Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model.

    Georgia B. Vogelsang;Allan D. Hess;Gary Gordon;George W. Santos

  • Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.

    M J Kennedy;G B Vogelsang;R J Jones;E R Farmer

  • Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.

    A D Hess;P J Tutschka;G W Santos

  • 4‐Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T‐lymphocytes from the bone marrow graft

    Martin Körbling;Allan D. Hess;Peter J. Tutschka;Herbert Kaizer

  • CXCR4 Chemokine Receptor Signaling Induces Apoptosis in Acute Myeloid Leukemia Cells via Regulation of the Bcl-2 Family Members Bcl-XL, Noxa, and Bak

    Kimberly N. Kremer;Kevin L. Peterson;Paula A. Schneider;X. Wei Meng

  • Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.

    Robert B. Geller;Ahmed H. Esa;William E. Beschorner;Carmellita G. Frondoza

  • MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

    K L B Knorr;P A Schneider;X W Meng;H Dai

  • Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease

    Allan D. Hess;Christopher J. Thoburn

  • Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.

    Allan D. Hess;Anne C. Fischer

  • Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras

    Peter J. Tutschka;Allan D. Hess;William E. Beschorner;George W. Santos

Frequent Co-Authors

George W. Santos
George W. Santos Johns Hopkins University
Georgia Boyce Vogelsang
Georgia Boyce Vogelsang Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Judith E. Karp
Judith E. Karp Johns Hopkins University
Richard J. Jones
Richard J. Jones Johns Hopkins University
Hyam I. Levitsky
Hyam I. Levitsky Johns Hopkins University
Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
Richard F. Ambinder
Richard F. Ambinder Johns Hopkins University
John E. Wagner
John E. Wagner University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare-related careers, many of which benefit from additional nursing qualifications. For non-nurses seeking to enter the nursing field quickly, there are options like 12-month accelerated nursing programs online for non nurses. These programs are designed to build foundational nursing skills efficiently while allowing students to continue advancing in health sciences such as immunology.

Another popular pathway is enrolling in accelerated bsn programs for non nurses, which provide a streamlined route to becoming a registered nurse with a Bachelor of Science in Nursing. These programs complement immunology expertise, especially for those interested in clinical research or patient care involving immunological diseases.

For individuals looking for entry points into nursing with less rigorous admission criteria, easy lpn programs to get into offer a practical approach to becoming licensed practical nurses. This can serve as a valuable foundation for careers in healthcare that intersect with immunology, such as infection control or immunization clinics.

Finally, for those aiming at advanced practice roles, exploring easy nurse practitioner programs to get into can be a strategic move. Nurse practitioners with a background in immunology are well-positioned to specialize in immunology-related healthcare fields, including allergy and immunology clinics, leading to rewarding career opportunities.

Best Scientists Citing Allan D. Hess

Trending Scientists

Recently Published Articles